Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts.

Sepriano A, Ramiro S, van der Heijde D, van Gaalen F, Hoonhout P, Molto A, Saraux A, Ramonda R, Dougados M, Landewé R.

Ann Rheum Dis. 2020 Mar;79(3):324-331. doi: 10.1136/annrheumdis-2019-216516. Epub 2020 Jan 24.

PMID:
31980546
2.

Dactylitis in early spondyloarthritis. Data from the prospective French national cohort DESIR.

Wendling D, Prati C, Saraux A, Molto A, Pham T, Dougados M, Guillot X.

Joint Bone Spine. 2020 Jan 17. pii: S1297-319X(20)30005-1. doi: 10.1016/j.jbspin.2020.01.003. [Epub ahead of print] No abstract available.

PMID:
31958574
3.

Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis.

López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A.

RMD Open. 2019 Nov 21;5(2):e001108. doi: 10.1136/rmdopen-2019-001108. eCollection 2019.

4.

Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort.

López-Medina C, Molto A, Claudepierre P, Dougados M.

Ann Rheum Dis. 2020 Feb;79(2):209-216. doi: 10.1136/annrheumdis-2019-216218. Epub 2019 Nov 29.

PMID:
31784451
5.

European Network of Pregnancy Registers in Rheumatology (EuNeP)-an overview of procedures and data collection.

Meissner Y, Strangfeld A, Costedoat-Chalumeau N, Förger F, Goll D, Molto A, Özdemir R, Wallenius M, Fischer-Betz R.

Arthritis Res Ther. 2019 Nov 14;21(1):241. doi: 10.1186/s13075-019-2019-3.

6.

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.

Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.

7.

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.

Stolwijk C, Essers I, van den Bosch F, Dougados M, Etcheto A, van der Heijde D, Landewé R, Molto A, van Tubergen A, Boonen A.

Rheumatology (Oxford). 2019 Oct 26. pii: kez482. doi: 10.1093/rheumatology/kez482. [Epub ahead of print]

PMID:
31665462
8.

Baseline MRI inflammation is not a determinant of 5-year bone mineral density loss in patients with early spondyloarthritis.

Fechtenbaum M, Molto A, Roux C, Goupille P, Chevret S, Briot K.

Joint Bone Spine. 2020 Jan;87(1):63-68. doi: 10.1016/j.jbspin.2019.09.016. Epub 2019 Oct 11.

PMID:
31606496
9.

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.

Kiltz U, Landewé RBM, van der Heijde D, Rudwaleit M, Weisman MH, Akkoc N, Boonen A, Brandt J, Carron P, Dougados M, Gossec L, Jongkees M, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Niederman K, Sampaio-Barros PD, Slobodin G, Van den Bosch FE, van Tubergen A, van Weely S, Wiek D, Braun J.

Ann Rheum Dis. 2020 Feb;79(2):193-201. doi: 10.1136/annrheumdis-2019-216034. Epub 2019 Oct 11.

10.

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O.

RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.

11.

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.

PMID:
31413005
12.

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts.

Boel A, Molto A, van der Heijde D, Ciurea A, Dougados M, Gensler LS, Santos MJ, De Miguel E, Poddubnyy D, Rudwaleit M, van Tubergen A, van Gaalen FA, Ramiro S.

Ann Rheum Dis. 2019 Nov;78(11):1545-1549. doi: 10.1136/annrheumdis-2019-215707. Epub 2019 Jul 30.

13.

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients.

Gossec L, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Guis S, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Fayet F, Dougados M.

RMD Open. 2019 Jun 14;5(2):e000914. doi: 10.1136/rmdopen-2019-000914. eCollection 2019.

14.

Evaluation of the performances of 'typical' imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study.

Molto A, Gossec L, Lefèvre-Colau MM, Foltz V, Beaufort R, Laredo JD, Richette P, Dieude P, Goupille P, Feydy A, Dougados M.

RMD Open. 2019 May 28;5(1):e000918. doi: 10.1136/rmdopen-2019-000918. eCollection 2019.

15.

Novel DMARD monotherapy in rheumatoid arthritis.

Moltó A, Dougados M.

Lancet. 2019 Jun 8;393(10188):2277-2278. doi: 10.1016/S0140-6736(19)30768-8. Epub 2019 Jun 6. No abstract available.

PMID:
31180015
16.

Comorbidities in spondyloarthritis including psoriatic arthritis.

Moltó A, Dougados M.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):390-400. doi: 10.1016/j.berh.2018.09.002. Epub 2018 Nov 15.

PMID:
31171310
17.

Peripheral spondyloarthritis: Concept, diagnosis and treatment.

Molto A, Sieper J.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):357-368. doi: 10.1016/j.berh.2019.02.010. Epub 2019 Mar 2. Review.

PMID:
31171308
18.

Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort.

López-Medina C, Dougados M, Ruyssen-Witrand A, Moltó A.

Arthritis Res Ther. 2019 Jun 6;21(1):139. doi: 10.1186/s13075-019-1927-6.

19.

Effect of Gut Involvement in Patients with High Probability of Early Spondyloarthritis: Data from the DESIR Cohort.

Wendling D, Guillot X, Prati C, Miceli-Richard C, Molto A, Lories R, Dougados M.

J Rheumatol. 2019 Jun 1. pii: jrheum.181326. doi: 10.3899/jrheum.181326. [Epub ahead of print]

PMID:
31154418
20.

Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study.

López-Medina C, Moltó A, Dougados M.

J Rheumatol. 2020 Feb;47(2):211-217. doi: 10.3899/jrheum.181331. Epub 2019 Apr 15.

PMID:
30988127
21.

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients.

Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, Balandraud N, Mariette X, Pouplin S, Marhadour T, Schaeverbeke T, Sordet C, Dougados M.

Rheumatology (Oxford). 2019 Aug 1;58(8):1498-1499. doi: 10.1093/rheumatology/kez094. No abstract available.

PMID:
30915463
22.

Evaluation of the predictive validity of the ASAS axial spondyloarthritis criteria in the DESIR cohort.

Meghnathi B, Saraux A, Dougados M, Moltó A.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):797-802. Epub 2019 Mar 7.

PMID:
30873948
23.

Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort.

Derakhshan MH, Goodson NJ, Packham J, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and the ASAS-COMOSPA Investigators.

J Clin Med. 2019 Feb 26;8(3). pii: E281. doi: 10.3390/jcm8030281.

24.

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L.

Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.

25.

Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the World.

Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, Matsui K, Morita M, Suda M, Tada K, Takizawa N, Tamura N, Taniguchi A, Taniguchi Y, Tsuji S, Haji Y, Rokutanda R, Yanaoka H, Cheung PP, Gu J, Kim TH, Luo SF, Okada M, López Medina C, Molto A, Dougados M, Kobayashi S, van der Heijde D, Tomita T.

J Rheumatol. 2019 Aug;46(8):896-903. doi: 10.3899/jrheum.180412. Epub 2019 Feb 15.

PMID:
30770497
26.

Response to 'Everything we see is a perspective, not the truth' by Chattopadhyay et al.

Molto A, Sahuguet J, Fechtenbaum J, Etcheto A, López-Medina C, Richette P, Dougados M, Roux C, Briot K.

Ann Rheum Dis. 2019 Feb 13. pii: annrheumdis-2019-215131. doi: 10.1136/annrheumdis-2019-215131. [Epub ahead of print] No abstract available.

PMID:
30760473
27.

Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients.

López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, Charles B, Lafarge D, Beauvais C, Gossec L, Dougados M.

Joint Bone Spine. 2019 Oct;86(5):610-614. doi: 10.1016/j.jbspin.2019.01.023. Epub 2019 Feb 7.

PMID:
30738192
28.

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA).

Putrik P, Ramiro S, Moltó A, Keszei AP, Norton S, Dougados M, van der Heijde D, Landewé RBM, Boonen A.

Ann Rheum Dis. 2019 Apr;78(4):486-493. doi: 10.1136/annrheumdis-2018-214259. Epub 2019 Jan 23.

PMID:
30674477
29.

Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study.

Derakhshan MH, Goodson NJ, Packham JC, Sengupta R, Molto A, Marzo-Ortega H, Siebert S; BRITSpA and COMOSPA Investigators.

J Rheumatol. 2019 Jul;46(7):701-709. doi: 10.3899/jrheum.180538. Epub 2019 Jan 15.

30.

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort.

Nadon V, Moltó A, Etcheto A, Bessette L, Michou L, D'Agostino MA, Claudepierre P, Wendling D, Haraoui P, Dougados M.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):561-565. Epub 2018 Dec 19.

PMID:
30620273
31.

Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients.

Frantz C, Portier A, Etcheto A, Monnet D, Brezin A, Roure F, Elhai M, Burki V, Fabreguet I, Koumakis E, Payet J, Gossec L, Dougados M, Molto A.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):26-31. Epub 2018 Dec 19.

32.

Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis.

López-Medina C, Moltó A.

Best Pract Res Clin Rheumatol. 2018 Apr;32(2):241-253. doi: 10.1016/j.berh.2018.10.006. Epub 2018 Nov 16. Review.

PMID:
30527429
33.

Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.

Santos-Faria D, Dougados M, Gossec L, Perrot S, Moltó A.

Rheumatol Int. 2019 Jan;39(1):141-146. doi: 10.1007/s00296-018-4200-4. Epub 2018 Nov 9.

PMID:
30413924
34.

Low incidence of vertebral fractures in early spondyloarthritis: 5-year prospective data of the DESIR cohort.

Sahuguet J, Fechtenbaum J, Molto A, Etcheto A, López-Medina C, Richette P, Dougados M, Roux C, Briot K.

Ann Rheum Dis. 2019 Jan;78(1):60-65. doi: 10.1136/annrheumdis-2018-213922. Epub 2018 Nov 2.

PMID:
30389692
35.

Spinal Radiographic Progression in Early Axial Spondyloarthritis: Five-Year Results From the DESIR Cohort.

Ramiro S, van der Heijde D, Sepriano A, van Lunteren M, Moltó A, Feydy A, d'Agostino MA, Loeuille D, Dougados M, Reijnierse M, Claudepierre P.

Arthritis Care Res (Hoboken). 2019 Dec;71(12):1678-1684. doi: 10.1002/acr.23796. Epub 2019 Nov 14.

36.

Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus.

Gossec L, Molto A, Romand X, Puyraimond-Zemmour D, Lavielle M, Beauvais C, Senbel E, Flipo RM, Pouplin S, Richez C, Saraux A, Mézières M, Gutermann L, Gaudin P, Wendling D, Dougados M.

Joint Bone Spine. 2019 Jan;86(1):13-19. doi: 10.1016/j.jbspin.2018.08.006. Epub 2018 Sep 19. Review.

37.

Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology.

Gossec L, Guyard F, Leroy D, Lafargue T, Seiler M, Jacquemin C, Molto A, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Fautrel B, Servy H.

Arthritis Care Res (Hoboken). 2019 Oct;71(10):1336-1343. doi: 10.1002/acr.23768.

38.

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.

Navarro-Compán V, Otón T, Loza E, Almodóvar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estévez E, de Miguel E, González-Fernández C, Gratacós J, Ibáñez S, Juanola X, Maldonado-Cocco J, Moltó A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H.

Reumatol Clin. 2018 Sep 4. pii: S1699-258X(18)30173-6. doi: 10.1016/j.reuma.2018.07.014. [Epub ahead of print] English, Spanish.

39.

Reply.

Latourte A, Moltó A.

Arthritis Care Res (Hoboken). 2019 Aug;71(8):1150. doi: 10.1002/acr.23744. Epub 2019 Jul 3. No abstract available.

PMID:
30192080
40.

Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.

Meghnathi B, Claudepierre P, Dougados M, Moltó A.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1043-1048. Epub 2018 Aug 29.

PMID:
30183594
41.

Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review.

Lavielle M, Puyraimond-Zemmour D, Romand X, Gossec L, Senbel E, Pouplin S, Beauvais C, Gutermann L, Mezieres M, Dougados M, Molto A.

RMD Open. 2018 Jul 27;4(2):e000684. doi: 10.1136/rmdopen-2018-000684. eCollection 2018.

42.

Which scoring method depicts spinal radiographic damage in early axial spondyloarthritis best? Five-year results from the DESIR cohort.

Ramiro S, Claudepierre P, Sepriano A, van Lunteren M, Molto A, Feydy A, Antonietta d'Agostino M, Loeuille D, Dougados M, Reijnierse M, van der Heijde D.

Rheumatology (Oxford). 2018 Nov 1;57(11):1991-2000. doi: 10.1093/rheumatology/key185.

PMID:
30053219
43.

Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.

Rodrigues Manica S, Sepriano A, Ramiro S, Pimentel Santos F, Putrik P, Nikiphorou E, Norton S, Molto A, Dougados M, van der Heijde D, Landewé RBM, van den Bosch FE, Boonen A.

Ann Rheum Dis. 2018 Sep;77(9):1303-1310. doi: 10.1136/annrheumdis-2018-213464. Epub 2018 Jun 2.

PMID:
29860232
44.

Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis.

Rosine N, Etcheto A, Hendel-Chavez H, Seror R, Briot K, Molto A, Chanson P, Taoufik Y, Wendling D, Lories R, Berenbaum F, van den Berg R, Claudepierre P, Feydy A, Dougados M, Roux C, Miceli-Richard C.

Sci Rep. 2018 May 16;8(1):7731. doi: 10.1038/s41598-018-25722-z.

45.

The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study.

Couderc M, Pereira B, Molto A, Tiple A, Soubrier M, Dougados M.

J Rheumatol. 2018 Jun;45(6):795-801. doi: 10.3899/jrheum.170133. Epub 2018 Apr 15.

PMID:
29657148
47.

Comorbidities in Spondyloarthritis.

Moltó A, Nikiphorou E.

Front Med (Lausanne). 2018 Mar 12;5:62. doi: 10.3389/fmed.2018.00062. eCollection 2018. Review.

48.

Improving the peer review skills of young rheumatologists and researchers in rheumatology: the EMEUNET Peer Review Mentoring Program.

Rodríguez-Carrio J, Putrik P, Sepriano A, Moltó A, Nikiphorou E, Gossec L, Kvien TK, Ramiro S.

RMD Open. 2018 Feb 16;4(1):e000619. doi: 10.1136/rmdopen-2017-000619. eCollection 2018. Review.

49.

Adherence to recommendations for the use of anti-tumour necrosis factor and its impact over 5 years of follow-up in axial spondyloarthritis.

López-Medina C, Dougados M, Collantes-Estévez E, Moltó A.

Rheumatology (Oxford). 2018 May 1;57(5):880-890. doi: 10.1093/rheumatology/kex514.

PMID:
29474666
50.

Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis.

Bahuaud M, Beaudouin-Bazire C, Husson M, Molto A, Launay O, Batteux F, Dougados M.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1464-1470. doi: 10.1080/21645515.2018.1438091. Epub 2018 Apr 9.

Supplemental Content

Support Center